STOCK TITAN

Charles Schwab Rule 144 Filing Shows Proposed 24,000-Share Sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Notice of proposed sale of securities under Rule 144 by an insider related to The Charles Schwab Corporation.

The filer reports a planned sale of 24,000 common shares with an aggregate market value of $2,219,393.00 and lists the approximate sale date as 10/02/2025 on the NYSE. Those shares were acquired as a gift on 02/14/2022 from Charles R. Schwab. The company has 1,815,219,300 shares outstanding, so the proposed block is immaterial relative to total outstanding shares. The filing also discloses three reported sales by the same account in the past three months: 24,000 shares on 08/07/2025 for $2,320,656.00, 13,542 shares on 08/25/2025 for $1,300,802.00, and 24,000 shares on 09/04/2025 for $2,319,300.00. The filer certifies there is no undisclosed material information.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: Routine Rule 144 notice for a relatively small insider sale; no material impact on shares outstanding.

This Form 144 notifies the market of a proposed sale of 24,000 Charles Schwab common shares valued at about $2.22 million. Given total shares outstanding of 1.815 billion, the block is immaterial to capital structure and is consistent with routine insider liquidity events. The filing documents the shares were received as a gift in 2022 and lists prior small sales in August and September 2025. There are no disclosures of material nonpublic information in the form. From an earnings and valuation perspective, this document contains no operating results or balance sheet changes.

TL;DR: Proper disclosure of insider sales under Rule 144; procedural compliance observed.

The form includes required details: acquisition date, nature of acquisition (gift), donor identity, planned sale date, broker name, and recent sales in the prior three months. This satisfies Rule 144 notice requirements and the insider attests to lack of undisclosed material adverse information. There is no indication of unusual timing or concentrated disposals that would raise immediate governance concerns based on the data provided.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 filed for SCHW report?

The form reports a proposed sale of 24,000 Charles Schwab common shares valued at $2,219,393.00 with an approximate sale date of 10/02/2025.

Who acquired the shares being sold and how were they acquired?

The 24,000 shares were acquired as a gift on 02/14/2022 from Charles R. Schwab.

Are there recent insider sales by the same person?

Yes. The filing lists three sales in the past three months: 24,000 shares on 08/07/2025 for $2,320,656.00, 13,542 shares on 08/25/2025 for $1,300,802.00, and 24,000 shares on 09/04/2025 for $2,319,300.00.

How large is the proposed sale relative to total shares outstanding?

The issuer reports 1,815,219,300 shares outstanding; the proposed 24,000-share sale is immaterial relative to that total.

Does the filing indicate any undisclosed material information?

The person signing the notice represents they do not know any material adverse information about the issuer that has not been publicly disclosed.